A major new study from Intermountain Health in Salt Lake City has found that popular weight loss drugs do not raise the risk ...

Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms.

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

Brooks Nader has kept it candid when it comes to her use of weight-loss drugs.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

It’s impossible to avoid headlines about GLP-1 medications. The weight-loss drugs target hormones in the gut and brain that ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 ...

In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than ...

There’s room for more than one winner in this race for GLP-1 weight loss supremacy, but some of these winners are going to be ...

So it was the government shutdown and some insane comments from OpenAI about a government backstop because of gigantic ...